Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
出版年份 2022 全文链接
标题
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 219, Issue 7, Pages -
出版商
Rockefeller University Press
发表日期
2022-06-16
DOI
10.1084/jem.20220638
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2022) Delphine Planas et al. NATURE
- Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
- (2022) Elisabetta Cameroni et al. NATURE
- Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
- (2022) Yunlong Cao et al. NATURE
- mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
- (2022) Henning Gruell et al. NATURE MEDICINE
- Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
- (2022) Peter B. Gilbert et al. SCIENCE
- COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination
- (2022) Ivan Gentile et al. PLOS MEDICINE
- SARS-CoV-2: Recent Variants and Clinical Efficacy of Antibody-Based Therapy
- (2022) Desh Deepak Singh et al. Frontiers in Cellular and Infection Microbiology
- Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller
- (2022) Valérie Lorin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies
- (2022) Timothée Bruel et al. NATURE MEDICINE
- LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
- (2022) Kathryn Westendorf et al. Cell Reports
- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
- (2021) C. Garrett Rappazzo et al. SCIENCE
- A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
- (2021) Cheolmin Kim et al. Nature Communications
- Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
- (2021) Yunjiao Zhou et al. Cell Reports
- Deep Sequencing of B Cell Receptor Repertoires From COVID-19 Patients Reveals Strong Convergent Immune Signatures
- (2021) Jacob D. Galson et al. Frontiers in Immunology
- The antigenic anatomy of SARS-CoV-2 receptor binding domain
- (2021) Wanwisa Dejnirattisai et al. CELL
- Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
- (2021) Emanuele Andreano et al. CELL
- Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
- (2021) Aurélien Sokal et al. CELL
- Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
- (2021) Emma S. Winkler et al. CELL
- Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera
- (2021) Daming Zhou et al. CELL
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
- (2021) Ronit Rosenfeld et al. Nature Communications
- Antibody evasion by the P.1 strain of SARS-CoV-2
- (2021) Wanwisa Dejnirattisai et al. CELL
- Sera neutralizing activities against SARS-CoV-2 and multiple variants six month after hospitalization for COVID-19
- (2021) Maureen Betton et al. CLINICAL INFECTIOUS DISEASES
- Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
- (2021) Delphine Planas et al. NATURE MEDICINE
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
- (2021) Bryan E. Jones et al. Science Translational Medicine
- Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice
- (2021) Tal Noy-Porat et al. iScience
- Tackling COVID-19 with neutralizing monoclonal antibodies
- (2021) Davide Corti et al. CELL
- Attenuation of clinical and immunological outcomes during SARS‐CoV‐2 infection by ivermectin
- (2021) Guilherme Dias Melo et al. EMBO Molecular Medicine
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
- (2021) Zijun Wang et al. NATURE
- SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
- (2021) Tyler N. Starr et al. NATURE
- High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape
- (2021) Fabian Schmidt et al. NATURE
- Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection
- (2021) Nikaïa Smith et al. NATURE IMMUNOLOGY
- A correlate of protection for SARS-CoV-2 vaccines is urgently needed
- (2021) Florian Krammer NATURE MEDICINE
- Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
- (2021) Lingshu Wang et al. SCIENCE
- Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants
- (2021) Meng Yuan et al. SCIENCE
- Broad betacoronavirus neutralization by a stem helix–specific human antibody
- (2021) Dora Pinto et al. SCIENCE
- Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers
- (2021) Edurne Rujas et al. Nature Communications
- Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
- (2021) Elaine C. Chen et al. Cell Reports
- Current status of therapeutic monoclonal antibodies against SARS-CoV-2
- (2021) Sanjeev Kumar et al. PLoS Pathogens
- Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail
- (2021) Jinhui Dong et al. Nature Microbiology
- Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers
- (2021) Kanika Vanshylla et al. Cell Host & Microbe
- Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG
- (2021) Lin Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS-CoV-2 B.1.1.7 (alpha) and B.1.351 (beta) variants induce pathogenic patterns in K18-hACE2 transgenic mice distinct from early strains
- (2021) Peter Radvak et al. Nature Communications
- Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants
- (2021) Pengcheng Han et al. Nature Communications
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- A human neutralizing antibody targets the receptor binding site of SARS-CoV-2
- (2020) Rui Shi et al. NATURE
- Human neutralizing antibodies elicited by SARS-CoV-2 infection
- (2020) Bin Ju et al. NATURE
- Pathogenesis and transmission of SARS-CoV-2 in golden hamsters
- (2020) Sin Fun Sia et al. NATURE
- Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
- (2020) Dora Pinto et al. NATURE
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Developing therapeutic monoclonal antibodies at pandemic pace
- (2020) Brian Kelley NATURE BIOTECHNOLOGY
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
- (2020) Christopher O. Barnes et al. CELL
- Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
- (2020) Yunlong Cao et al. CELL
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals
- (2020) Davide F. Robbiani et al. NATURE
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
- (2020) Lihong Liu et al. NATURE
- Potently neutralizing and protective human antibodies against SARS-CoV-2
- (2020) Seth J. Zost et al. NATURE
- Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
- (2020) Seth J. Zost et al. NATURE MEDICINE
- Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
- (2020) Jennifer A. Juno et al. NATURE MEDICINE
- Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
- (2020) Masaki Imai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
- (2020) Xiangyang Chi et al. SCIENCE
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
- (2020) Thomas F. Rogers et al. SCIENCE
- Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
- (2020) Ching-Lin Hsieh et al. SCIENCE
- Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail
- (2020) Johanna Hansen et al. SCIENCE
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
- (2020) Philip J. M. Brouwer et al. SCIENCE
- Broad neutralization of SARS-related viruses by human monoclonal antibodies
- (2020) Anna Z. Wec et al. SCIENCE
- Structural basis of a shared antibody response to SARS-CoV-2
- (2020) Meng Yuan et al. SCIENCE
- A Therapeutic Non-self-reactive SARS-CoV-2 Antibody Protects from Lung Pathology in a COVID-19 Hamster Model
- (2020) Jakob Kreye et al. CELL
- Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients
- (2020) Christoph Kreer et al. CELL
- Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2
- (2020) Sandra C.A. Nielsen et al. Cell Host & Microbe
- Syncytia formation by SARS‐CoV‐2 infected cells
- (2020) Julian Buchrieser et al. EMBO JOURNAL
- SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
- (2020) Christopher O. Barnes et al. NATURE
- Structures and distributions of SARS-CoV-2 spike proteins on intact virions
- (2020) Zunlong Ke et al. NATURE
- Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
- (2020) M. Alejandra Tortorici et al. SCIENCE
- A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations
- (2020) Ludivine Grzelak et al. Science Translational Medicine
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
- (2020) Allison J. Greaney et al. Cell Host & Microbe
- High seroprevalence but short‐lived immune response to SARS‐CoV‐2 infection in Paris
- (2020) François Anna et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo
- (2020) Alexandra Schäfer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction
- (2020) Ali Punjani et al. NATURE METHODS
- Enhanced SARS-CoV-2 neutralization by dimeric IgA
- (2020) Zijun Wang et al. Science Translational Medicine
- IgA dominates the early neutralizing antibody response to SARS-CoV-2
- (2020) Delphine Sterlin et al. Science Translational Medicine
- HIV-1 Envelope Recognition by Polyreactive and Cross-Reactive Intestinal B Cells
- (2019) Cyril Planchais et al. Cell Reports
- Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix
- (2019) Dorothee Liebschner et al. Acta Crystallographica Section D-Structural Biology
- New tools for automated high-resolution cryo-EM structure determination in RELION-3
- (2018) Jasenko Zivanov et al. eLife
- MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy
- (2017) Shawn Q Zheng et al. NATURE METHODS
- cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
- (2017) Ali Punjani et al. NATURE METHODS
- MolProbity: More and better reference data for improved all-atom structure validation
- (2017) Christopher J. Williams et al. PROTEIN SCIENCE
- Scarcity of autoreactive human blood IgA+memory B cells
- (2016) Julie Prigent et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Efficient generation of human IgA monoclonal antibodies
- (2015) Valérie Lorin et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Viral Concentration Determination Through Plaque Assays: Using Traditional and Novel Overlay Systems
- (2014) Alan Baer et al. Jove-Journal of Visualized Experiments
- Human Circulating PD-1+CXCR3−CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses
- (2013) Michela Locci et al. IMMUNITY
- Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
- (2012) H. Mouquet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human Blood CXCR5+CD4+ T Cells Are Counterparts of T Follicular Cells and Contain Specific Subsets that Differentially Support Antibody Secretion
- (2011) Rimpei Morita et al. IMMUNITY
- Memory B Cell Antibodies to HIV-1 gp140 Cloned from Individuals Infected with Clade A and B Viruses
- (2011) Hugo Mouquet et al. PLoS One
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Engineering of recombinant crystallization chaperones
- (2009) Shohei Koide CURRENT OPINION IN STRUCTURAL BIOLOGY
- Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
- (2007) Thomas Tiller et al. JOURNAL OF IMMUNOLOGICAL METHODS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started